Community Pharmacy England, the Department of Health and Social Care (DHSC) and NHS England have announced the 2024/25 and 2025/26 funding settlement for community pharmacy. This briefing outlines the key elements of the settlement. Briefing 010/25: Funding Settlement for 2024/25 and 2025/26 Details of the settlement on the CPCF for 2024/25 and 2025/26 are also
This Community Pharmacy England Briefing provides information on the changes to the discount deduction scale were implemented by the Department of Health and Social Care (DHSC) in October 2022. This briefing explains why the changes were introduced and how the current discount deduction system works. Briefing 009/25: Discount Deduction Scale The post Briefing 009/25: Briefing
This Community Pharmacy England Briefing provides information for general practice teams on the Community Pharmacy RSV and Pertussis Vaccination Service, which has been commissioned from selected pharmacies by NHS England. Briefing 008.25 Briefing for general practice teams on NHS RSV and Pertussis Vaccination Service The post Briefing 008/25: Briefing for general practice teams – the
This Community Pharmacy England Briefing provides information for pharmacy teams on the Respiratory Syncytial Virus (RSV) vaccination and Pertussis vaccination programmes which is commissioned as a National Enhanced service from selected pharmacies from May 2025. CPE Briefing 007.25 Briefing for pharmacy teams on RSV & Pertussis Vaccination Service The post Briefing 007/25: Briefing for pharmacy
Community Pharmacy England met in London for a full Committee Meeting on 5th and 6th February 2025. Committee discussions covered key topics including in-depth consideration of the 2024/25 and 2025/26 negotiations, as well as Community Pharmacy England’s budget, levy and workplans for the coming financial year. The Committee also considered ongoing matters relating to governance
This factsheet sets out for pharmacy teams which EPS tokens are required to be submitted alongside the paper prescription bundle at the end of each month to the NHSBSA. Briefing 005/25 EPS token submission The post Briefing 005/25: EPS token submission appeared first on Community Pharmacy England.
In this factsheet we explain how to reduce the risk of delays to payment caused by timing issues with electronic prescriptions. Briefing 004/25 Claiming for EPS prescriptions on time The post Briefing 004/25: Claiming for EPS prescriptions on time appeared first on Community Pharmacy England.
GP practice staff and community pharmacy teams at business change workshops can use this action plan to note and plan how to complete agreed actions ahead of a go-live date. Briefing 003/25 eRD business change workshop actions list template The post Briefing 003/25: eRD business change workshop: actions list appeared first on Community Pharmacy England.
This briefing contains content to support community pharmacy and general practice teams in planning the rollout and use of eRD to optimise its benefits for patients, pharmacies and practices. Briefing 002/25 Working with GP practices to roll out eRD and optimise its use The post Briefing 002/25: Working with GP practices to roll out eRD
These briefings will assist community pharmacy contractors completing the Data Security and Protection Toolkit (‘Toolkit’) 2025: Toolkit completion: Five steps to complete the Toolkit (overview) Toolkit completion: Question-by-question guidance (mandatory questions) (PDF ver) Toolkit completion: Question-by-question guidance (all questions) (spreadsheet ver) Toolkit completion: Using the Data Security and Protection Toolkit’s HQ batch submission feature – step-by-step
The benefits of eRD for patients, GP practices and community pharmacy teams are many and are includes in this factsheet. Briefing 028/24 Electronic Repeat Dispensing (eRD) benefits The post Briefing 028/24: Electronic Repeat Dispensing (eRD) benefits appeared first on Community Pharmacy England.
eRD allows the prescriber to authorise and issue repeat prescriptions electronically. eRD prescription issues include the usual information on electronic prescription service (EPS) prescriptions and additionally, the interval between each issue (e.g. 28 days) and how many times the repeatable prescription can be issued (e.g. 13 times). The steps in the eRD cycle are described
